enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Bright Minds Biosciences and Firefly Neuroscience to ...

   lite.aol.com/tech/story/0022/20241021/9258929.htm

   NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, today announced that it is once again collaborating with Firefly Neuroscience, Inc. (Firefly) (NASDAQ: AIFF), an Artificial ...

3. BMB-202 - Wikipedia

   en.wikipedia.org/wiki/BMB-202

   BMB-202 is under development by Bright Minds Biosciences. [ 1 ] [ 2 ] As of April 2023, it is in preclinical research for depressive disorders and PTSD. [ 1 ] [ 2 ] The chemical structure of BMB-202 does not yet appear to have been disclosed, [ 1 ] [ 2 ] but it seems that it may be a phenethylamine . [ 5 ]

4. Bright Minds' Second-Gen Psychedelic Drugs Ready to Be ... - AOL

   www.aol.com/news/bright-minds-second-gen...

   Bright Minds Biosciences (OTC: BMBIF), a Canadian-based biotechnology company, is developing the next-generation serotonergic drugs to treat various central nervous system (CNS) disorders. Over ...

5. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   homepage.aol.com

   Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.

6. 3 Russell 2000 Growth Stocks That Could Be Worth the Risk - AOL

   www.aol.com/3-russell-2000-growth-stocks...

   Keeping with this theme, analysts are bullish on Longboard Pharmaceuticals stock. The current consensus price target on the biotech implies a hefty 49% upside over the next 12 months.

7. Why Is Senti Biosciences Stock Surging Over 400% On Monday? - AOL

   www.aol.com/finance/why-senti-biosciences-stock...

   Senti Biosciences, Inc. (NASDAQ:SNTI) stock is skyrocketing on Monday, with a strong session volume of 73.4 million compared to an average volume of 17.81 thousand, as per data from Benzinga Pro.

8. BMB-201 - Wikipedia

   en.wikipedia.org/wiki/BMB-201

   BMB-201 is under development by Bright Minds Biosciences. [ 1 ] [ 2 ] As of October 2024, its highest developmental phase is preclinical research . [ 1 ] [ 2 ] The chemical structure of BMB-201 does not yet appear to have been disclosed.

9. Why Emergent BioSciences Stock Plummeted Today - AOL

   www.aol.com/finance/why-emergent-biosciences...

   Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The selling parties are mainly entities affiliated with OHA Agency, a business that provided a ...